Filing: 0001791827-26-000004
Total Filing Value
$493.81MIssuer | Symbol | Class | CUSIP | Value | Shares | Put/Call |
|---|---|---|---|---|---|---|
| DIANTHUS THERAPEUTICS INC | DNTH | COM | 252828108 | $176,583,121 | 2,104,184 | — |
| CG ONCOLOGY INC | CGON | COM | 156944100 | $87,236,001 | 1,288,948 | — |
| ORUKA THERAPEUTICS INC | ORKA | COM | 687604108 | $37,298,797 | 760,424 | — |
| PERSPECTIVE THERAPEUTICS INC | COM NEW | 46489V302 | $25,228,496 | 6,049,999 | — | |
| JADE BIOSCIENCES INC | JBIO | COM NEW | 008064206 | $19,679,947 | 1,400,708 | — |
| ENLIVEN THERAPEUTICS INC | ELVN | COM | 29337E102 | $15,680,000 | 400,000 | — |
| TEVA PHARM ADR | TEVA | COM | 881624209 | $13,557,012 | 450,100 | — |
| CONTEXT THERAPEUTICS INC | CNTX | COM | 21077P108 | $13,095,460 | 4,998,267 | — |
| REPLIGEN CORP | RGEN | COM | 759916109 | $9,166,396 | 77,800 | — |
| PALVELLA THERAPEUTICS INC | COM | 697947109 | $8,725,500 | 70,000 | — | |
| MEDTRONIC INC | MDT | SHS | G5960L103 | $8,665,000 | 100,000 | — |
| VIR BIOTECHNOLOGY INC | VIR | COM | 92764N102 | $8,512,000 | 950,000 | — |
| AKTIS ONCOLOGY INC | COM | 01021M104 | $8,382,646 | 468,566 | — | |
| IMMUNIC INC | IMUX | COM | 4525EP101 | $7,436,346 | 6,699,411 | — |
| DEXCOM | DXCM | COM | 252131107 | $5,652,000 | 90,000 | — |
| ENCOMPASS HEALTH CORP | EHC | COM | 29261A100 | $4,062,660 | 42,000 | — |
| BOSTON SCIENTIFIC CORPORATION | BSX | COM | 101137107 | $3,765,000 | 60,000 | — |
| TENAX THERAPEUTICS INC | COM NEW | 88032L605 | $3,452,785 | 215,934 | — | |
| GILEAD SCIENCES INC | GILD | COM | 375558103 | $2,787,400 | 20,000 | — |
| PHATHOM PHARMACEUTICALS INC | PHAT | COM | 71722W107 | $2,770,723 | 249,390 | — |
Rows:
1–20 of 45